N/A
Completed N=30
ClearUP Longitudinal Pilot Study
Sinus Pain · Congestion
Source: ClinicalTrials.gov NCT03888274 ↗
Enrolled (actual)
30
Serious AEs
0.0%
Results posted
Apr 2020
Primary outcomePrimary: Numeric Rating Scale for Pain — 6.5; 3.6 score on a scale
Summary
Single arm, open label pilot study assessing the longitudinal home use of ClearUp Sinus Pain Relief for four weeks.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Numeric Rating Scale for Pain |
6.5; 4.3 | — |
| SECONDARY Congestion Quantifier 7 |
18.1; 11.0 | — |
| SECONDARY Numeric Rating Scale for Pain |
6.5; 4.3 | — |
Eligibility Criteria
Inclusion Criteria
- 18-71 years of age (inclusive)
- Present with symptoms of sinus pain or facial pain in the forehead, periorbital, facial, or nasal region
- Current pain score ≥ 5 (Numeric Rating Scale 0-10)
- Frequency of sinus/facial pain at least twice weekly for 1 month
- Able to read and understand English
- Agree to participate in the study
- Able and willing to provide Informed Consent
Exclusion Criteria
- Do not meet Inclusion Criteria
- Currently taking or recently taken any oral steroid medications in the last 90 days
- Sinus surgery in previous 90 days
- History of Chronic Migraine (≥ 15 headache days per month)
- Pain location in the vertex, occiput, or temporal region of the skull or in mandibular region
- Purulent rhinorrhea
Data sourced from ClinicalTrials.gov (NCT03888274). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.